These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7025578)

  • 1. Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1981 May; 112(1):57-63. PubMed ID: 7025578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrin releasing peptide (GRP): effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Pettersson M; Ahrén B
    Peptides; 1987; 8(1):55-60. PubMed ID: 3554168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.
    Ahrén B; Lundquist I
    Acta Diabetol Lat; 1981; 18(4):345-56. PubMed ID: 6277122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1985 Oct; 125(2):211-7. PubMed ID: 2866660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretory response to different secretagogues in hyper- and hypothyroid mice.
    Ahrén B; Lundquist I
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):508-13. PubMed ID: 6115531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of 2-deoxy-glucose-induced insulin secretion in the mouse.
    Karlsson S; Bood M; Ahrén B
    J Auton Pharmacol; 1987 Jun; 7(2):135-44. PubMed ID: 3308892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.
    Savontaus E; Fagerholm V; Rahkonen O; Scheinin M
    Eur J Pharmacol; 2008 Jan; 578(2-3):359-64. PubMed ID: 17964569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and alpha-adrenoceptor blockade in the mouse.
    Karlsson S; Ahrén B
    Diabetes Res Clin Pract; 1987; 3(4):239-42. PubMed ID: 2887409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective and non-selective beta-adrenergic agents on insulin secretion in vivo.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1981 Apr; 71(1):93-104. PubMed ID: 6113155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse.
    Skoglund G; Lundquist I; Ahrén B
    Eur J Pharmacol; 1987 Nov; 143(1):83-8. PubMed ID: 2891547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peptide HI on basal and stimulated insulin and glucagon secretion in the mouse.
    Ahrén B; Lundquist I
    Neuropeptides; 1988; 11(4):159-62. PubMed ID: 3047591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic muscarinic effects on insulin release in mice.
    Lundquist I
    Pharmacology; 1982; 25(6):338-47. PubMed ID: 6818565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenoceptor blockade by phentolamine inhibits beta-adrenergically and cholinergically induced glucagon secretion in the mouse.
    Ahrén B; Lundquist I
    Horm Metab Res; 1987 Dec; 19(12):600-3. PubMed ID: 2894339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-adrenoceptor induced increase of plasma insulin levels in man: evidence of direct and indirect B-cell stimulation and liver effects.
    Ahrén B; Scherstén B
    Diabetes Res; 1986 Nov; 3(9):443-5. PubMed ID: 3030608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of helodermin and VIP on insulin and glucagon secretion in the mouse.
    Ahrén B; Falck B
    Regul Pept; 1991 Jan; 32(1):1-9. PubMed ID: 2003148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helodermin stimulates glucagon secretion in the mouse.
    Ahrén B
    Peptides; 1989; 10(3):709-11. PubMed ID: 2674915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of insulin on skeletal muscle contractions and its relation to the effect produced by BETA-adrenoceptor stimulation.
    Holmberg E; Waldeck B
    Acta Physiol Scand; 1980 Jun; 109(2):225-9. PubMed ID: 6999834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.